BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 8

• Press Releases

  Lilly’s olomorasib receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain newly diagnosed metastatic KRAS G12C-mutant lung cancers

  September 4, 2025

   · 

  8 min read
• Press Releases

  CorVista Health Announces Publication of Real-World Case Series in the Journal of the American College of Cardiology Exploring its Non-Invasive Test for Earlier Diagnosis of Pulmonary Hypertension

  September 4, 2025

   · 

  5 min read
• Press Releases

  AL-S Pharma announces positive topline results from Phase 2 study of AP-101 for the treatment of amyotrophic lateral sclerosis (ALS)

  September 4, 2025

   · 

  6 min read
• Press Releases

  Real-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical’s RECELL® System

  September 4, 2025

   · 

  5 min read
• Press Releases

  Sentec Receives FDA Clearance for LuMon™ Electrical Impedance Tomography (EIT) System -- First EIT System Indicated for Premature Infants and for Spontaneously Breathing Patients in the United States

  September 4, 2025

   · 

  3 min read
• Press Releases

  BPGbio Announces Completion of Enrollment for Phase 2b Trial of BPM31510 for Glioblastoma (GBM)

  September 4, 2025

   · 

  5 min read
• Press Releases

  Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 4, 2025

  September 4, 2025

   · 

  2 min read
• Press Releases

  Syantra, Inc., announces new therapeutic division for immuno-oncology drug discovery, leveraging its patent-pending Onco-ID™ platform

  September 4, 2025

   · 

  2 min read
• Press Releases

  TG Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

  September 4, 2025

   · 

  1 min read
• Press Releases

  Zevra Therapeutics Presents Positive New Data Supporting Foundational Role of MIPLYFFA® (arimoclomol) for the Treatment of Niemann-Pick Disease Type C at the International Congress of Inborn Errors of Metabolism (ICIEM)

  September 4, 2025

   · 

  8 min read